Statistics from Altmetric.com
Waiting for evidence is sometime like waiting for Godot. The question is obvious, but the trial is never done. One such often-asked question is whether treating high blood pressure in the very elderly is worthwhile. Maybe they will not respond as well as the younger patients? And maybe they will have more adverse effects, or are likely to die of something else before they can benefit? Hence my colleagues have …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.